Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 5
Submit an article Journal homepage
425
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing

Fleur A. de Groota Department of Hematology, Leiden University Medical Center, Leiden, The NetherlandsORCID Iconhttps://orcid.org/0000-0001-9940-2891
ORCID Icon,
Lorraine M. de Haanb Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
,
Ruben A. L. de Groena Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands
,
Linda Heijmenc Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
,
Tom van Wezelb Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
,
Ronald van Eijkb Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
,
Lara Bohmerd Department of Hematology, Haga Hospital, The Hague, The Netherlands
,
Freek Bote Department of Pathology, Haga Hospital, The Hague, The Netherlands
,
Rosita L. ten Bergee Department of Pathology, Haga Hospital, The Hague, The Netherlands
,
Arjan Diepstraf Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
,
Hendrik Veelkena Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands
,
Arjen H. G. Clevenb Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
,
Patty M. Jansenb Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
&
Joost S. P. Vermaata Department of Hematology, Leiden University Medical Center, Leiden, The NetherlandsCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1628-6256
ORCID Icon show all
Pages 1251-1255 | Received 24 Sep 2021, Accepted 29 Nov 2021, Published online: 21 Dec 2021

References

  • Montoto S, Fitzgibbon J. Transformation of indolent B-cell lymphomas. J Clin Oncol. 2011;29(14):1827–1834.
  • Miyaoka M, Kikuchi T, Carreras J, et al. Composite follicular lymphoma and CD5-positive nodal marginal zone lymphoma. J Clin Exp Hematop. 2016;56(1):55–58.
  • Mohammad F, Garcia G, Kedia S, et al. Composite diffuse large B-cell and mantle cell lymphoma: a case report. Cureus. 2017;9(1):e963.
  • Ho AK, Teman CJ, Smith GP, et al. Composite mantle cell and diffuse large B-cell lymphoma: report of two cases. Int J Surg Pathol. 2011;19(5):643–648.
  • Liu Z, Dong HY, Gorczyca W, et al. CD5- mantle cell lymphoma. Am J Clin Pathol. 2002;118(2):216–224.
  • Adams HJ, de Klerk JM, Fijnheer R, et al. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma. Eur J Haematol. 2015;94(6):532–539.
  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
  • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282.
  • Vermaat JS, Somers SF, de Wreede LC, et al. MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis. Haematologica. 2020;105(2):424–434.
  • Bailly C, Carlier T, Berriolo-Riedinger A, et al. Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET project. Haematologica. 2020;105(1):e33–e36.
  • Scott DW, Wright GW, Williams PM, et al. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood. 2014;123(8):1214–1217.
  • de Groen RA, van Eijk R, Boehringer S, et al. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. Blood Adv. 2021;5(19):3760–3775.
  • Chapuy B, Stewart C, Dunford AJ, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679–690.
  • Bea S, Valdes-Mas R, Navarro A, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A. 2013;110(45):18250–18255.
  • Wang M, Fowler N, Wagner-Bartak N, et al. Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial. Leukemia. 2013;27(9):1902–1909.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.